AFP/Google.com Examines Use Of Surrogate Mothers Among Gay Male Couples AFP/Google.com on Tuesday examined the increasing number of gay male couples who are having children through surrogacy services. According to AFP/Google.com, the number of gay couples in the U.S. who have children through surrogacy or adoption is increasing. The
Source: www.medicalnewstoday.comNKTR-118 Shows Substantial Oral Bioavailability And Extended Half-Life In Phase 1 Clinical Data Presented At American Pain Society Meeting New Phase 1 clinical trial results for NKTR-118 (oral PEG-naloxol) were presented by Nektar Therapeutics (Nasdaq: NKTR) this week at the Annual Meeting of the American Pain Society (APS) in Tampa, Florida. In this multiple-dose Phase 1 study, oral NKTR-118 was shown to have substantial oral bioavailability with rapid absorption and an extended half-life that is up to ten times the known half-life of unPEGylated naloxone.
Source: www.medicalnewstoday.comBonaventura Reproductive Medicine To Offer Pioneering Test Of A Woman's Biological Clock Bonaventura Reproductive
Medicine announced it will offer the Repromedix's PlanAhead test, an innovative blood test that provides an assessment of a woman's egg supply by combining multiple factors including the measurement of ovary-related hormones AMH, Inhibin B, and FSH. The window of opportunity for a woman to have children by natural conception is dependent upon an adequate supply of eggs, which inevitably declines as a woman ages and her "biological clock ticks.
Source: www.medicalnewstoday.comWal-Mart Adds Prescription Women's Health Medications To Discount Drug Program Wal-Mart Stores on Monday announced that it is adding several women's
health-related medications to its discounted
prescription drug program, the Wall Street Journal reports. Wal-Mart pharmacies will provide $9 generic
prescriptions for up to 30-day supplies of several
drugs that treat breast cancer, hormone deficiency, menopause and osteoporosis (Zimmerman, Wall Street Journal, 5/6).
Source: www.medicalnewstoday.comNational Community Pharmacists Association Statement On "Sense Of Congress" Resolution Opposing FDA Restrictions On Estriol Usage Yesterday H. Con. Res. 342 was introduced by Rep. Mike Ross (D-Ark.) and Jo Ann Emerson (R-Mo.) opposing the Food and Drug Administration's (FDA) decision to restrict Estriol (a form of Estrogen), a compounded hormone preparation used by women to alleviate the symptoms of menopause. The action was taken after the FDA sent letters to seven pharmacies in January asking them to cease and desist with the use of estriol.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 12:00 PM
